Daniel H Deon

Title: Daniel H Deon: Innovator in Thromboembolic Disorder Treatment

Introduction

Daniel H Deon is a notable inventor based in Denver, CO (US). He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that inhibit platelet aggregation. His work is crucial for advancing treatments for thromboembolic disorders.

Latest Patents

Daniel H Deon holds a patent for "Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregation." This invention provides thiazole compounds of Formula I, which are designed to inhibit platelet aggregation and can be utilized as medicaments for treating or preventing thromboembolic disorders. The patent outlines various chemical structures and their potential applications in medicine.

Career Highlights

Throughout his career, Daniel has worked with prominent organizations, including Bristol-Myers Squibb Company and Université de Montréal. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Daniel has collaborated with notable colleagues such as Jacques Banville and Roger Rémillard. These partnerships have enriched his research and expanded the impact of his inventions.

Conclusion

Daniel H Deon is a distinguished inventor whose work in developing PAR4 inhibitors represents a significant advancement in the treatment of thromboembolic disorders. His contributions to medicinal chemistry continue to influence the field positively.